APO Research
Talk to an analyst

APO RESEARCH · REPORT

Urticaria Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Urticaria Drug Market Analysis and Forecast 2026-2032

1 January 2026190 pages

Choose your research edition.

Industry ResearchUrticaria Drug Industry Research Report 2026123 pages · $2,950 USDIndustry Growth & TrendsGlobal Urticaria Drug Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Urticaria Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Urticaria Drug Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Urticaria Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Urticaria Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Urticaria Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Urticaria Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Urticaria Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Urticaria Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Urticaria Drug include Akorn, Amneal Pharmaceuticals, Genentech, Taro Pharmaceutical Industries Novartis AG, Xolair, Pfizer, Johnson and Johnson Services and Teva Pharmaceutical Industries, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Urticaria Drug, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Urticaria Drug, also provides the sales of main regions and countries. Of the upcoming market potential for Urticaria Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Urticaria Drug sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Urticaria Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Urticaria Drug sales, projected growth trends, production technology, application and end-user industry.

Urticaria Drug Segment by Company

Akorn

Amneal Pharmaceuticals

Genentech

Taro Pharmaceutical Industries Novartis AG

Xolair

Pfizer

Johnson and Johnson Services

Teva Pharmaceutical Industries

Urticaria Drug Segment by Type

Acute Urticaria

Chronic Urticaria

Urticaria Drug Segment by Application

Retail Pharmacies

Online Pharmacies

Hospital Pharmacies

Others

Urticaria Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Urticaria Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Urticaria Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Urticaria Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Urticaria Drug in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Urticaria Drug manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Urticaria Drug sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Urticaria Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Acute Urticaria Major Manufacturers Table 3. Chronic Urticaria Major Manufacturers Table 4. Global Urticaria Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacies Major Manufacturers Table 6. Online Pharmacies Major Manufacturers Table 7. Hospital Pharmacies Major Manufacturers Table 8. Others Major Manufacturers Table 9. Urticaria Drug Industry Trends Table 10. Urticaria Drug Industry Drivers Table 11. Urticaria Drug Industry Opportunities and Challenges Table 12. Urticaria Drug Industry Restraints Table 13. Global Urticaria Drug Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Urticaria Drug Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Urticaria Drug Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Urticaria Drug Revenue Market Share by Region (2021-2026) Table 17. Global Urticaria Drug Revenue Market Share by Region (2027-2032) Table 18. Global Urticaria Drug Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Urticaria Drug Sales by Region (2021-2026) & (K Units) Table 20. Global Urticaria Drug Sales by Region (2027-2032) & (K Units) Table 21. Global Urticaria Drug Sales Market Share by Region (2021-2026) Table 22. Global Urticaria Drug Sales Market Share by Region (2027-2032) Table 23. Global Urticaria Drug Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Urticaria Drug Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Urticaria Drug Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Urticaria Drug Sales Market Share by Manufacturers (2021-2026) Table 27. Global Urticaria Drug Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Urticaria Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Urticaria Drug Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Urticaria Drug Manufacturers, Product Type & Application Table 31. Global Urticaria Drug Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Urticaria Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Urticaria Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Urticaria Drug Revenue Market Share by Type (2021-2026) Table 38. Global Urticaria Drug Revenue Market Share by Type (2027-2032) Table 39. Global Urticaria Drug Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 41. Global Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 42. Global Urticaria Drug Sales Market Share by Type (2021-2026) Table 43. Global Urticaria Drug Sales Market Share by Type (2027-2032) Table 44. Global Urticaria Drug Price by Type (2021-2026) & (US$/Unit) Table 45. Global Urticaria Drug Price by Type (2027-2032) & (US$/Unit) Table 46. Global Urticaria Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Urticaria Drug Revenue Market Share by Application (2021-2026) Table 50. Global Urticaria Drug Revenue Market Share by Application (2027-2032) Table 51. Global Urticaria Drug Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 53. Global Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 54. Global Urticaria Drug Sales Market Share by Application (2021-2026) Table 55. Global Urticaria Drug Sales Market Share by Application (2027-2032) Table 56. Global Urticaria Drug Price by Application (2021-2026) & (US$/Unit) Table 57. Global Urticaria Drug Price by Application (2027-2032) & (US$/Unit) Table 58. Akorn Company Information Table 59. Akorn Business Overview Table 60. Akorn Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Akorn Urticaria Drug Product Portfolio Table 62. Akorn Recent Development Table 63. Amneal Pharmaceuticals Company Information Table 64. Amneal Pharmaceuticals Business Overview Table 65. Amneal Pharmaceuticals Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Amneal Pharmaceuticals Urticaria Drug Product Portfolio Table 67. Amneal Pharmaceuticals Recent Development Table 68. Genentech Company Information Table 69. Genentech Business Overview Table 70. Genentech Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Genentech Urticaria Drug Product Portfolio Table 72. Genentech Recent Development Table 73. Taro Pharmaceutical Industries Novartis AG Company Information Table 74. Taro Pharmaceutical Industries Novartis AG Business Overview Table 75. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio Table 77. Taro Pharmaceutical Industries Novartis AG Recent Development Table 78. Xolair Company Information Table 79. Xolair Business Overview Table 80. Xolair Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Xolair Urticaria Drug Product Portfolio Table 82. Xolair Recent Development Table 83. Pfizer Company Information Table 84. Pfizer Business Overview Table 85. Pfizer Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Pfizer Urticaria Drug Product Portfolio Table 87. Pfizer Recent Development Table 88. Johnson and Johnson Services Company Information Table 89. Johnson and Johnson Services Business Overview Table 90. Johnson and Johnson Services Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Johnson and Johnson Services Urticaria Drug Product Portfolio Table 92. Johnson and Johnson Services Recent Development Table 93. Teva Pharmaceutical Industries Company Information Table 94. Teva Pharmaceutical Industries Business Overview Table 95. Teva Pharmaceutical Industries Urticaria Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Teva Pharmaceutical Industries Urticaria Drug Product Portfolio Table 97. Teva Pharmaceutical Industries Recent Development Table 98. North America Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 99. North America Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 100. North America Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 101. North America Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 102. North America Urticaria Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 103. North America Urticaria Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 104. North America Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 105. North America Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 106. North America Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 107. North America Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 108. North America Urticaria Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 109. North America Urticaria Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 110. North America Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 111. North America Urticaria Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 112. North America Urticaria Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 113. North America Urticaria Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 114. North America Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 115. North America Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 116. North America Urticaria Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 117. North America Urticaria Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 118. United States Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 119. Canada Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 120. Europe Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 121. Europe Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 122. Europe Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 123. Europe Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 124. Europe Urticaria Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 125. Europe Urticaria Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 126. Europe Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 127. Europe Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 128. Europe Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 129. Europe Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 130. Europe Urticaria Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 131. Europe Urticaria Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 132. Europe Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 133. Europe Urticaria Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 134. Europe Urticaria Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 135. Europe Urticaria Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 136. Europe Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 137. Europe Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 138. Europe Urticaria Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 139. Europe Urticaria Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 140. Germany Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 141. France Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 142. U.K. Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 143. Italy Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 145. China Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 146. China Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 147. China Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 148. China Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 149. China Urticaria Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 150. China Urticaria Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 151. China Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 152. China Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 153. China Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 154. China Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 155. China Urticaria Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 156. China Urticaria Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 157. Asia Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 158. Asia Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 159. Asia Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 160. Asia Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 161. Asia Urticaria Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 162. Asia Urticaria Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 163. Asia Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 164. Asia Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 165. Asia Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 166. Asia Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 167. Asia Urticaria Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 168. Asia Urticaria Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 169. Asia Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 170. Asia Urticaria Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 171. Asia Urticaria Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 172. Asia Urticaria Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 173. Asia Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 174. Asia Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 175. Asia Urticaria Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 176. Asia Urticaria Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 177. Japan Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 178. South Korea Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 179. India Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 180. Australia Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 181. China Taiwan Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 182. Southeast Asia Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 183. SAMEA Urticaria Drug Revenue by Type (2021-2026) & (US$ Million) Table 184. SAMEA Urticaria Drug Revenue by Type (2027-2032) & (US$ Million) Table 185. SAMEA Urticaria Drug Sales by Type (2021-2026) & (K Units) Table 186. SAMEA Urticaria Drug Sales by Type (2027-2032) & (K Units) Table 187. SAMEA Urticaria Drug Sales Price by Type (2021-2026) & (US$/Unit) Table 188. SAMEA Urticaria Drug Sales Price by Type (2027-2032) & (US$/Unit) Table 189. SAMEA Urticaria Drug Revenue by Application (2021-2026) & (US$ Million) Table 190. SAMEA Urticaria Drug Revenue by Application (2027-2032) & (US$ Million) Table 191. SAMEA Urticaria Drug Sales by Application (2021-2026) & (K Units) Table 192. SAMEA Urticaria Drug Sales by Application (2027-2032) & (K Units) Table 193. SAMEA Urticaria Drug Sales Price by Application (2021-2026) & (US$/Unit) Table 194. SAMEA Urticaria Drug Sales Price by Application (2027-2032) & (US$/Unit) Table 195. SAMEA Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 196. SAMEA Urticaria Drug Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 197. SAMEA Urticaria Drug Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 198. SAMEA Urticaria Drug Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 199. SAMEA Urticaria Drug Sales by Country (2021-2026) & (K Units) Table 200. SAMEA Urticaria Drug Sales by Country (2027-2032) & (K Units) Table 201. SAMEA Urticaria Drug Sales Price by Country (2021-2026) & (US$/Unit) Table 202. SAMEA Urticaria Drug Sales Price by Country (2027-2032) & (US$/Unit) Table 203. Brazil Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 204. Argentina Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 205. Chile Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 206. Colombia Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 207. Peru Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 208. Saudi Arabia Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 209. Israel Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 210. UAE Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 211. Turkey Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 212. Iran Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 213. Egypt Urticaria Drug Revenue (2021-2032) & (US$ Million) Table 214. Key Raw Materials Table 215. Raw Materials Key Suppliers Table 216. Urticaria Drug Distributors List Table 217. Urticaria Drug Customers List Table 218. Research Programs/Design for This Report Table 219. Authors List of This Report Table 220. Secondary Sources Table 221. Primary Sources List of Figures Figure 1. Urticaria Drug Image Figure 2. Global Urticaria Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Urticaria Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Acute Urticaria Image Figure 5. Chronic Urticaria Image Figure 6. Global Urticaria Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Urticaria Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacies Image Figure 9. Online Pharmacies Image Figure 10. Hospital Pharmacies Image Figure 11. Others Image Figure 12. Global Urticaria Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Urticaria Drug Revenue (2021-2032) & (US$ Million) Figure 14. Global Urticaria Drug Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Urticaria Drug Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Urticaria Drug Revenue Market Share by Region (2021-2032) Figure 17. Global Urticaria Drug Sales (2021-2032) & (K Units) Figure 18. Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Urticaria Drug Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Urticaria Drug Sales YoY (2021-2032) & (K Units) Figure 21. Europe Urticaria Drug Sales YoY (2021-2032) & (K Units) Figure 22. China Urticaria Drug Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Urticaria Drug Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Urticaria Drug Sales YoY (2021-2032) & (K Units) Figure 25. Global Urticaria Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Urticaria Drug Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Urticaria Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Urticaria Drug Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Urticaria Drug Revenue Market Share by Type (2021-2032) Figure 31. Global Urticaria Drug Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Urticaria Drug Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Urticaria Drug Sales Market Share by Type (2021-2032) Figure 34. Global Urticaria Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Urticaria Drug Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Urticaria Drug Revenue Market Share by Application (2021-2032) Figure 37. Global Urticaria Drug Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Urticaria Drug Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Urticaria Drug Sales Market Share by Application (2021-2032) Figure 40. North America Urticaria Drug Revenue Share by Type (2021-2032) Figure 41. North America Urticaria Drug Sales Share by Type (2021-2032) Figure 42. North America Urticaria Drug Revenue Share by Application (2021-2032) Figure 43. North America Urticaria Drug Sales Share by Application (2021-2032) Figure 44. North America Urticaria Drug Revenue Share by Country (2021-2032) Figure 45. North America Urticaria Drug Sales Share by Country (2021-2032) Figure 46. Europe Urticaria Drug Revenue Share by Type (2021-2032) Figure 47. Europe Urticaria Drug Sales Share by Type (2021-2032) Figure 48. Europe Urticaria Drug Revenue Share by Application (2021-2032) Figure 49. Europe Urticaria Drug Sales Share by Application (2021-2032) Figure 50. Europe Urticaria Drug Revenue Share by Country (2021-2032) Figure 51. Europe Urticaria Drug Sales Share by Country (2021-2032) Figure 52. China Urticaria Drug Revenue Share by Type (2021-2032) Figure 53. China Urticaria Drug Sales Share by Type (2021-2032) Figure 54. China Urticaria Drug Revenue Share by Application (2021-2032) Figure 55. China Urticaria Drug Sales Share by Application (2021-2032) Figure 56. Asia Urticaria Drug Revenue Share by Type (2021-2032) Figure 57. Asia Urticaria Drug Sales Share by Type (2021-2032) Figure 58. Asia Urticaria Drug Revenue Share by Application (2021-2032) Figure 59. Asia Urticaria Drug Sales Share by Application (2021-2032) Figure 60. Asia Urticaria Drug Revenue Share by Country (2021-2032) Figure 61. Asia Urticaria Drug Sales Share by Country (2021-2032) Figure 62. SAMEA Urticaria Drug Revenue Share by Type (2021-2032) Figure 63. SAMEA Urticaria Drug Sales Share by Type (2021-2032) Figure 64. SAMEA Urticaria Drug Revenue Share by Application (2021-2032) Figure 65. SAMEA Urticaria Drug Sales Share by Application (2021-2032) Figure 66. SAMEA Urticaria Drug Revenue Share by Country (2021-2032) Figure 67. SAMEA Urticaria Drug Sales Share by Country (2021-2032) Figure 68. Urticaria Drug Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Urticaria Drug Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Acute Urticaria
  • Chronic Urticaria
Applications
  • Retail Pharmacies
  • Online Pharmacies
  • Hospital Pharmacies
  • Others
Companies covered
  • Akorn
  • Amneal Pharmaceuticals
  • Genentech
  • Taro Pharmaceutical Industries Novartis AG
  • Xolair
  • Pfizer
  • Johnson and Johnson Services
  • Teva Pharmaceutical Industries

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Urticaria Drug Market by Type
  3. 1.2.1 Global Urticaria Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Acute Urticaria
  5. 1.2.3 Chronic Urticaria
  6. 1.3 Urticaria Drug Market by Application
  7. 1.3.1 Global Urticaria Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacies
  9. 1.3.3 Online Pharmacies
  10. 1.3.4 Hospital Pharmacies
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Urticaria Drug Market Dynamics
  1. 2.1 Urticaria Drug Industry Trends
  2. 2.2 Urticaria Drug Industry Drivers
  3. 2.3 Urticaria Drug Industry Opportunities and Challenges
  4. 2.4 Urticaria Drug Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Urticaria Drug Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Urticaria Drug Revenue by Region
  3. 3.2.1 Global Urticaria Drug Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Urticaria Drug Revenue by Region (2021-2026)
  5. 3.2.3 Global Urticaria Drug Revenue by Region (2027-2032)
  6. 3.2.4 Global Urticaria Drug Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Urticaria Drug Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Urticaria Drug Sales by Region
  9. 3.4.1 Global Urticaria Drug Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Urticaria Drug Sales by Region (2021-2026)
  11. 3.4.3 Global Urticaria Drug Sales by Region (2027-2032)
  12. 3.4.4 Global Urticaria Drug Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Urticaria Drug Revenue by Manufacturers
  2. 4.1.1 Global Urticaria Drug Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Urticaria Drug Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Urticaria Drug Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Urticaria Drug Sales by Manufacturers
  6. 4.2.1 Global Urticaria Drug Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Urticaria Drug Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Urticaria Drug Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Urticaria Drug Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Urticaria Drug Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Urticaria Drug Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Urticaria Drug Manufacturers, Product Type & Application
  13. 4.7 Global Urticaria Drug Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Urticaria Drug Market CR5 and HHI
  16. 4.8.2 2025 Urticaria Drug Tier 1, Tier 2, and Tier 3
5 Urticaria Drug Market by Type
  1. 5.1 Global Urticaria Drug Revenue by Type
  2. 5.1.1 Global Urticaria Drug Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Urticaria Drug Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Urticaria Drug Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Urticaria Drug Sales by Type
  6. 5.2.1 Global Urticaria Drug Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Urticaria Drug Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Urticaria Drug Sales Market Share by Type (2021-2032)
  9. 5.3 Global Urticaria Drug Price by Type
6 Urticaria Drug Market by Application
  1. 6.1 Global Urticaria Drug Revenue by Application
  2. 6.1.1 Global Urticaria Drug Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Urticaria Drug Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Urticaria Drug Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Urticaria Drug Sales by Application
  6. 6.2.1 Global Urticaria Drug Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Urticaria Drug Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Urticaria Drug Sales Market Share by Application (2021-2032)
  9. 6.3 Global Urticaria Drug Price by Application
7 Company Profiles
  1. 7.1 Akorn
  2. 7.1.1 Akorn Company Information
  3. 7.1.2 Akorn Business Overview
  4. 7.1.3 Akorn Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Akorn Urticaria Drug Product Portfolio
  6. 7.1.5 Akorn Recent Developments
  7. 7.2 Amneal Pharmaceuticals
  8. 7.2.1 Amneal Pharmaceuticals Company Information
  9. 7.2.2 Amneal Pharmaceuticals Business Overview
  10. 7.2.3 Amneal Pharmaceuticals Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Amneal Pharmaceuticals Urticaria Drug Product Portfolio
  12. 7.2.5 Amneal Pharmaceuticals Recent Developments
  13. 7.3 Genentech
  14. 7.3.1 Genentech Company Information
  15. 7.3.2 Genentech Business Overview
  16. 7.3.3 Genentech Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Genentech Urticaria Drug Product Portfolio
  18. 7.3.5 Genentech Recent Developments
  19. 7.4 Taro Pharmaceutical Industries Novartis AG
  20. 7.4.1 Taro Pharmaceutical Industries Novartis AG Company Information
  21. 7.4.2 Taro Pharmaceutical Industries Novartis AG Business Overview
  22. 7.4.3 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Taro Pharmaceutical Industries Novartis AG Urticaria Drug Product Portfolio
  24. 7.4.5 Taro Pharmaceutical Industries Novartis AG Recent Developments
  25. 7.5 Xolair
  26. 7.5.1 Xolair Company Information
  27. 7.5.2 Xolair Business Overview
  28. 7.5.3 Xolair Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Xolair Urticaria Drug Product Portfolio
  30. 7.5.5 Xolair Recent Developments
  31. 7.6 Pfizer
  32. 7.6.1 Pfizer Company Information
  33. 7.6.2 Pfizer Business Overview
  34. 7.6.3 Pfizer Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Pfizer Urticaria Drug Product Portfolio
  36. 7.6.5 Pfizer Recent Developments
  37. 7.7 Johnson and Johnson Services
  38. 7.7.1 Johnson and Johnson Services Company Information
  39. 7.7.2 Johnson and Johnson Services Business Overview
  40. 7.7.3 Johnson and Johnson Services Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Johnson and Johnson Services Urticaria Drug Product Portfolio
  42. 7.7.5 Johnson and Johnson Services Recent Developments
  43. 7.8 Teva Pharmaceutical Industries
  44. 7.8.1 Teva Pharmaceutical Industries Company Information
  45. 7.8.2 Teva Pharmaceutical Industries Business Overview
  46. 7.8.3 Teva Pharmaceutical Industries Urticaria Drug Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva Pharmaceutical Industries Urticaria Drug Product Portfolio
  48. 7.8.5 Teva Pharmaceutical Industries Recent Developments
8 North America
  1. 8.1 North America Urticaria Drug Market Size by Type
  2. 8.1.1 North America Urticaria Drug Revenue by Type (2021-2032)
  3. 8.1.2 North America Urticaria Drug Sales by Type (2021-2032)
  4. 8.1.3 North America Urticaria Drug Price by Type (2021-2032)
  5. 8.2 North America Urticaria Drug Market Size by Application
  6. 8.2.1 North America Urticaria Drug Revenue by Application (2021-2032)
  7. 8.2.2 North America Urticaria Drug Sales by Application (2021-2032)
  8. 8.2.3 North America Urticaria Drug Price by Application (2021-2032)
  9. 8.3 North America Urticaria Drug Market Size by Country
  10. 8.3.1 North America Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Urticaria Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Urticaria Drug Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Urticaria Drug Market Size by Type
  2. 9.1.1 Europe Urticaria Drug Revenue by Type (2021-2032)
  3. 9.1.2 Europe Urticaria Drug Sales by Type (2021-2032)
  4. 9.1.3 Europe Urticaria Drug Price by Type (2021-2032)
  5. 9.2 Europe Urticaria Drug Market Size by Application
  6. 9.2.1 Europe Urticaria Drug Revenue by Application (2021-2032)
  7. 9.2.2 Europe Urticaria Drug Sales by Application (2021-2032)
  8. 9.2.3 Europe Urticaria Drug Price by Application (2021-2032)
  9. 9.3 Europe Urticaria Drug Market Size by Country
  10. 9.3.1 Europe Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Urticaria Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Urticaria Drug Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Urticaria Drug Market Size by Type
  2. 10.1.1 China Urticaria Drug Revenue by Type (2021-2032)
  3. 10.1.2 China Urticaria Drug Sales by Type (2021-2032)
  4. 10.1.3 China Urticaria Drug Price by Type (2021-2032)
  5. 10.2 China Urticaria Drug Market Size by Application
  6. 10.2.1 China Urticaria Drug Revenue by Application (2021-2032)
  7. 10.2.2 China Urticaria Drug Sales by Application (2021-2032)
  8. 10.2.3 China Urticaria Drug Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Urticaria Drug Market Size by Type
  2. 11.1.1 Asia Urticaria Drug Revenue by Type (2021-2032)
  3. 11.1.2 Asia Urticaria Drug Sales by Type (2021-2032)
  4. 11.1.3 Asia Urticaria Drug Price by Type (2021-2032)
  5. 11.2 Asia Urticaria Drug Market Size by Application
  6. 11.2.1 Asia Urticaria Drug Revenue by Application (2021-2032)
  7. 11.2.2 Asia Urticaria Drug Sales by Application (2021-2032)
  8. 11.2.3 Asia Urticaria Drug Price by Application (2021-2032)
  9. 11.3 Asia Urticaria Drug Market Size by Country
  10. 11.3.1 Asia Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Urticaria Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Urticaria Drug Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Urticaria Drug Market Size by Type
  2. 12.1.1 SAMEA Urticaria Drug Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Urticaria Drug Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Urticaria Drug Price by Type (2021-2032)
  5. 12.2 SAMEA Urticaria Drug Market Size by Application
  6. 12.2.1 SAMEA Urticaria Drug Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Urticaria Drug Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Urticaria Drug Price by Application (2021-2032)
  9. 12.3 SAMEA Urticaria Drug Market Size by Country
  10. 12.3.1 SAMEA Urticaria Drug Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Urticaria Drug Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Urticaria Drug Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Urticaria Drug Value Chain Analysis
  2. 13.1.1 Urticaria Drug Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Urticaria Drug Production Mode & Process
  6. 13.2 Urticaria Drug Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Urticaria Drug Distributors
  9. 13.2.3 Urticaria Drug Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst